About
Fenwick, founded in 1987 and based in San Francisco, CA, is a law firm focused on technology and life sciences companies. It advises clients from early-stage startups to publicly traded corporations across corporate, intellectual property, litigation, regulatory, and tax matters. The corporate team counsels on startups and venture capital, capital markets, mergers and acquisitions, executive compensation and benefits, and corporate governance. Its capital markets practice guides issuers through initial public offerings and other equity and debt offerings, including SPAC transactions, direct listings, and reverse mergers.
Fenwick also handles patent, copyright, trademark, privacy and cybersecurity, trade secrets, and related disputes, including PTAB proceedings, securities enforcement and litigation, and white collar investigations, as well as antitrust, government contracts, healthcare and fintech regulatory issues, trade and national security, and tax.
Representative work includes advising Day One Biopharmaceuticals on its $2.5 billion acquisition by Servier, serving as lead transaction counsel to Wiz in its $32 billion acquisition by Google, and advising Figma on its $1.2 billion IPO and Wealthfront on its $484 million IPO. The firm has been recognized by Law360 as Life Sciences & Tech Practice Group of the Year (2024) and Capital Markets Group of the Year (2021).